The PurpleLab



In the ever-evolving landscape of healthcare, deciphering claims data has proven to be a formidable challenge for payers and providers alike. How does PurpleLab’s data help health plans transform their claims data into actionable insights? Watch this webinar with Dr. Russell Robbins, CMIO at PurpleLab, and Dr. Aaron Novotny, Director of Health Economics at Arkansas…

Solution Sheets

CLEAR Claims Payer & Provider Payer & Provider Download


In 2019, the National Multiple Sclerosis Society published a series of findings with updated prevalence of the disease. Current estimates place the number of people diagnosed with Multiple Sclerosis (MS) at one million people in the US; double previously reported figures. It is a costly and chronic disease without an exact known cause or biomarker,…


February is low-vision month, and at PurpleLab we are focusing on Age-Related Macular Degeneration (AMD), one of the diseases responsible for this condition.  According to the Centers for Disease Control’s (CDC) Vision and Eye Health Surveillance System (VEHSS) about twenty million Americans aged forty and older are living with AMD; 1.5 million of which are…


When the pandemic struck in 2019, there were more than 51 million Americans experiencing some type of mental illness.